Habil Khorakiwala on India's First FDA-Approved Antibiotic.

Wockhardt's FDA approval of Zaynich marks a historic first, the only drug entirely discovered and developed by an Indian company to clear US-FDA scrutiny. ET’s pharma editor Vikas Dandekar and Rica Bhattacharyya talk to Habil Khorakiwala, Chairperson of Wockhardt who unpacks the 25-year innovation …

Jio Studios’ Dream To Be Part of a Global $100B Industry

What does it take to back India's highest-grossing films three years in a row? Host Anirban Chowdhury and ET’s film journalist and critic Rajesh N Naidu talk to Jyoti Deshpande, President - Jio Studios, Media & Content Business -Reliance Industries Ltd, who pulls back the curtain on how she green-l…

Corner Office Conversation: HP India MD Ipsita Dasgupta on AI PCs & Creator Economy

HP’s MD and SVP for India, Bangladesh and Sri Lanka Ipsita Dasgupta joins ET’s Anirban Chowdhury in the latest Corner Office Conversation to discuss why India’s PC story is still in its early stages — and how AI PCs, creators, SMEs and students could drive the next wave of growth. She explains why …

Dara Khosrowshahi - India To Be Uber’s No. 1 Market

Uber CEO Dara Khosrowshahi says India could become Uber’s largest market globally over the next decade and on whether he is open to a partnership with Travis Kalanick. In this conversation with ET’s editor, ETtech.com, editor-startups, emerging business, new economy Samidha Sharma and Pranav Mukul,…

How Guneet Monga Rewrote Bollywood's Rules and Won an Oscar Doing It

She grew up navigating a war zone of a family home, arrived in Bombay with ₹50 lakhs borrowed from a neighbour, and watched her debut film get pulled from theatres the morning after India lost the cricket World Cup. That's where most stories end. Guneet Monga's was just beginning. In this candid, f…

Corner Office Conversation with G.V. Prasad, Co-Chairman and Managing Director Dr Reddy’s Laboratories Ltd

G.V. Prasad has spent over thirty years at the helm of Dr. Reddy's Laboratories — long enough to know where the opportunities were missed and where the potential and challenges lie. In a candid conversation with ET’s pharma editor Vikas Dandekar on Corner Office Conversation, the Co-Chairman and Ma…

Arvind Krishna: Cutting Through the AI Noise

In a wide-ranging conversation with host Surabhi Agarwal, IBM's chairman, president and CEO Arvind Krishna addresses the questions every technology leader and IT professional in India is wrestling with right now. He pushes back on AI doomsday narratives for software services, makes a compelling cas…

Corner Office Conversation with Dilip Shanghvi, Chairman of Sun Pharma and Glenn Saldanha, Managing Director at Glenmark Pharma

In a candid, unscripted exchange, India’s pharma titans peeled back the mythology of overnight success to reveal a harder truth: conviction compounded over decades. What began as two products and a bet on neglected therapy areas evolved into a multibillion-dollar enterprise riding India’s epidemiol…

Corner office Conversation with T Krishnakumar, Director of Reliance Consumer Products

In a market long dominated by premium playbooks, Director of Reliance Consumer Products, T Krishnakumar is scripting a different FMCG story. Handpicked by Mukesh Ambani to build Reliance Consumer Products from scratch, he talks to host Ratna Bhushan about his strategy: targeting India's 500–600 mil…

Corner Office Conversation with Rajan Anandan, Managing Director, Peak XV & Surge

India's AI revolution demands strategic vision beyond enthusiasm. Host Anirban Chowdhury talks to Rajan Anand, Managing Director of Peak XV and Surge a former Microsoft India head and Google VP shaping India's venture landscape. With 120 unicorns and 300 IPOs last year, India is poised for transfor…